Literature DB >> 11926403

Reproductive options for individuals at risk for transmission of a genetic disorder.

Shirley L Jones1, Lee A Fallon.   

Abstract

The basis of human growth and development has long been considered to be one of the great mysteries of science and mankind. The portal to understanding this mystery was achieved by the Human Genome Project and Celera Genomics in 2001, with their joint announcement of the sequencing of 99% of the human genome map. Current reproductive options, however, remain restricted to the prevention of transmitting an at-risk gene or genes, but do not include treatment or cure. It is anticipated that this state of "halfway technology" will continue for years to come. As such, the scientific and ethical issues associated with each of these reproductive options will continue to affect the decision making of at-risk individuals. As the omnipresent health care provider, nurses have a duty to know and disseminate accurate and current information about reproductive options for individuals at risk for transmission of a genetic disorder. Nurses also have a duty to advocate for and ensure the privacy and confidentiality of genetic information.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2002        PMID: 11926403     DOI: 10.1111/j.1552-6909.2002.tb00040.x

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  3 in total

Review 1.  Unraveling preimplantation genetic diagnosis for high-risk couples: implications for nurses at the front line of care.

Authors:  Patricia E Hershberger; Catherine Schoenfeld; Ilan Tur-Kaspa
Journal:  Nurs Womens Health       Date:  2011 Feb-Mar

Review 2.  Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Authors:  Norita Hussein; Stephen F Weng; Joe Kai; Jos Kleijnen; Nadeem Qureshi
Journal:  Cochrane Database Syst Rev       Date:  2018-03-14

Review 3.  The arrogance of teratology: A brief chronology of attitudes throughout history.

Authors:  John M DeSesso
Journal:  Birth Defects Res       Date:  2018-12-04       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.